poisar

Stock

Insmed Incorporated INSM

$126.33-4.50%

Overview

INSM market data

Price History

INSM price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$6.42
Diluted earnings per share over the trailing twelve months.
Beta
0.86
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-76.9%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$90.39 – $212.75
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $28.5B · P/B 50.23 · P/S 25.01.

Company News

10 captured
JP Morgan Maintains Overweight on Insmed, Lowers Price Target to $175Benzinga · Aug 10, 2026, 6:53 PM
Truist Securities Reiterates Buy on Insmed, Raises Price Target to $195Benzinga · Aug 10, 2026, 5:53 PM
Guggenheim Maintains Buy on Insmed, Lowers Price Target to $205Benzinga · Aug 7, 2026, 5:04 PM
Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $169Benzinga · Aug 7, 2026, 1:56 PM
Evercore ISI Group Maintains Outperform on Insmed, Raises Price Target to $170Benzinga · Aug 7, 2026, 12:40 PM
S&P 500, Dow Fall as Brent Jumps 4%, SanDisk Trims Losses: Stock Market TodayBenzinga · Aug 6, 2026, 5:32 PM
Crude Oil Gains 2%; Keurig Dr Pepper Earnings Top ViewsBenzinga · Aug 6, 2026, 4:04 PM
Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks Moving Higher On ThursdayBenzinga · Aug 6, 2026, 2:01 PM
Insmed shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.Benzinga · Aug 6, 2026, 11:25 AM
Insmed Q2 EPS $(0.06) Beats $(0.73) Estimate, Sales $425.486M Beat $392.836M EstimateBenzinga · Aug 6, 2026, 11:10 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock